Table 3 Distribution of pretreatment drug resistance according to PI, NRTI, NNRTI and INSTI dug classes and HIV-1 subtypes.
ID_project | HIV-1 subtypes | Pretreatment drug resistance | |||
|---|---|---|---|---|---|
PI | NRTI | NNRTI | INST | ||
HIT21 | F1 | None | None | Y188L (86%; cov = 30.907) | None |
HIT127 | C | None | None | K101E (35%; cov = 17.019) | None |
HIT166 | C | I85V (86%; cov = 29.235) | None | K103N (87%; cov = 29.208) | None |
HIT225 | C | None | None | Y181C (88%; cov = 1.812) | None |
HIT919 | A1 | None | None | K101E (45%; cov = 9.060) Y181C (89%; cov = 8.900) G190A (94%; cov = 8.895) | None |
HIT1002 | H | None | None | K103N (88%; cov = 56.083) | None |
HIT1218 | C | None | None | K101E (48%; cov = 27.180) Y181C (88%; cov = 25.956) G190S (91%; cov = 25.922) | None |
HIT1281 | C | None | None | V106M (85%; cov = 11.805) | None |
HIT1523 | F1 | None | M41L (88%; cov = 1.938) | None | None |
HIT1808 | F1 | None | None | K103N (89%; cov = 7.434) | None |
